Research Article
Efficacy and Safety of Lianhuaqingwen Capsules for the Prevention of Coronavirus Disease 2019: A Prospective Open-Label Controlled Trial
Table 10
Proportion of subjects with symptoms during the medical observation period.
| | Follow-up timepoint | Symptomaticity | N = 1976 | value | LH group
(N = 1101) | Control group
(N = 875) |
| | Isolation period | Symptomatic, N (%) | 7 (0.64) | 17 (1.94) | 0.0084 | | Asymptomatic, N (%) | 1094 (99.36) | 858 (98.06) |
|
|
